CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $70,369,463
- in 12 filings, $45.5M under 10b5-1 plans
Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-22 | Kumar Rakhi Chief Accounting Officer | Grant or award | −38,685 | 216,573 | ||
| 2024-04-22 | Kumar Rakhi Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +230,548 | 230,548 | ||
| 2024-04-22 | Pulik Richard CFO | Grant or award | +38,685 | 297,382 | ||
| 2024-04-22 | Pulik Richard CFO | Grant or award · Stock Option (Right to Buy) | +302,594 | 302,594 | ||
| 2024-04-20 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −10,945 | $10.46 | $114K | 1,153,706 |
| 2024-04-20 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −8,515 | $10.46 | $89K | 258,697 |
| 2024-04-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −9,881 | $10.46 | $103K | 177,888 |
| 2024-04-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −16,002 | $10.46 | $167K | 484,200 |
| 2024-03-30 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise 10b5-1 | +729,081 | 4,018,196 | ||
| 2024-03-30 | Sukhatme Mayukh Pres&Chief Investment Officer | Shares withheld for taxes 10b5-1 | −366,211 | $10.54 | $3.9M | 3,651,985 |
| 2024-03-30 | Sukhatme Mayukh Pres&Chief Investment Officer | Option exercise · Capped Value Appreciation Rights 10b5-1 | −1,856,163 | $6.40 | $11.9M | 0 |
| 2024-03-30 | Gline Matthew CEO | Option exercise 10b5-1 | +390,579 | 1,380,642 | ||
| 2024-03-30 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −215,991 | $10.54 | $2.3M | 1,164,651 |
| 2024-03-30 | Gline Matthew CEO | Option exercise · Capped Value Appreciation Rights 10b5-1 | −994,373 | $6.40 | $6.4M | 0 |
| 2024-03-28 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −2,341 | $10.54 | $25K | 267,212 |
| 2024-03-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −16,003 | $10.01 | $160K | 500,202 |
| 2024-03-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −1,506 | $10.01 | $15K | 187,769 |
| 2024-03-20 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −10,945 | $10.01 | $110K | 990,063 |
| 2024-03-07 | MANCHESTER KEITH S Director | Other disposition | −11,077,765 | 14,646,796 | ||
| 2024-03-07 | MANCHESTER KEITH S Director | Other disposition | −11,325,233 | 23,105,358 |
Page 32 of 38 · 748 trades